India’s pharmaceutical exports seem to be kicking the drift. Just when the geopolitical pressures and worldwide demand collapse have led to a reduction in general goods exports, pharma exports soared 9.6% to hit $27.8 billion in FY24.  This is the largest export growth for the pharma segment in the past three years. Authorities said that main categories such as generic formulations (73% of entire exports) and API (active pharmaceuticals ingredients) segments observed healthy growth from critical markets such as the US, Africa, and Europe. The segment of Middle Eastern countries, which is at the center of geopolitical disorder, in total exports...